BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15694206)

  • 21. A new polymorphism in the proteolipid protein (PLP1) gene and its use for carrier detection of PLP1 gene duplication in Pelizaeus-Merzbacher disease.
    Hobson G; Stabley D; Funanage V; Marks H
    Hum Mutat; 2001 Feb; 17(2):152. PubMed ID: 11180600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant trafficking of a proteolipid protein in a mild Pelizaeus-Merzbacher disease.
    Koizume S; Takizawa S; Fujita K; Aida N; Yamashita S; Miyagi Y; Osaka H
    Neuroscience; 2006 Sep; 141(4):1861-9. PubMed ID: 16844304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene.
    Hudson LD
    J Child Neurol; 2003 Sep; 18(9):616-24. PubMed ID: 14572140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic background determines phenotypic severity of the Plp rumpshaker mutation.
    Al-Saktawi K; McLaughlin M; Klugmann M; Schneider A; Barrie JA; McCulloch MC; Montague P; Kirkham D; Nave KA; Griffiths IR
    J Neurosci Res; 2003 Apr; 72(1):12-24. PubMed ID: 12645075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.
    Elitt MS; Tesar PJ
    Trends Mol Med; 2024 May; 30(5):459-470. PubMed ID: 38582621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-related axonal and myelin changes in the rumpshaker mutation of the Plp gene.
    Edgar JM; McLaughlin M; Barrie JA; McCulloch MC; Garbern J; Griffiths IR
    Acta Neuropathol; 2004 Apr; 107(4):331-5. PubMed ID: 14745569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral neuropathy caused by proteolipid protein gene mutations.
    Garbern JY; Cambi F; Lewis R; Shy M; Sima A; Kraft G; Vallat JM; Bosch EP; Hodes ME; Dlouhy S; Raskind W; Bird T; Macklin W; Kamholz J
    Ann N Y Acad Sci; 1999 Sep; 883():351-65. PubMed ID: 10586260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disrupted compaction of CNS myelin in an OSP/Claudin-11 and PLP/DM20 double knockout mouse.
    Chow E; Mottahedeh J; Prins M; Ridder W; Nusinowitz S; Bronstein JM
    Mol Cell Neurosci; 2005 Jul; 29(3):405-13. PubMed ID: 15886014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication.
    Clark K; Sakowski L; Sperle K; Banser L; Landel CP; Bessert DA; Skoff RP; Hobson GM
    J Neurosci; 2013 Jul; 33(29):11788-99. PubMed ID: 23864668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
    Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
    Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelination of a fetus with Pelizaeus-Merzbacher disease: immunopathological study.
    Shiraishi K; Itoh M; Sano K; Takashima S; Kubota T
    Ann Neurol; 2003 Aug; 54(2):259-62. PubMed ID: 12891682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Duplication of the PLP gene and the classical form of Pelizaeus-Merzbacher disease].
    Blanco-Barca MO; Eirís-Puñal J; Soler-Regal C; Castro-Gago M
    Rev Neurol; 2003 Sep 1-15; 37(5):436-8. PubMed ID: 14533091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.
    Inoue K
    Neurogenetics; 2005 Feb; 6(1):1-16. PubMed ID: 15627202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the natural history of Pelizaeus-Merzbacher disease.
    Mayer JA; Griffiths IR; Goldman JE; Smith CM; Cooksey E; Radcliff AB; Duncan ID
    Neurobiol Dis; 2015 Mar; 75():115-30. PubMed ID: 25562656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential changes in axonal conduction following CNS demyelination in two mouse models.
    Bando Y; Takakusaki K; Ito S; Terayama R; Kashiwayanagi M; Yoshida S
    Eur J Neurosci; 2008 Nov; 28(9):1731-42. PubMed ID: 18973589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demyelination in peroxisomal diseases.
    Powers JM
    J Neurol Sci; 2005 Feb; 228(2):206-7. PubMed ID: 15694208
    [No Abstract]   [Full Text] [Related]  

  • 37. Mild phenotype in Pelizaeus-Merzbacher disease caused by a PLP1-specific mutation.
    Osaka H; Koizume S; Aoyama H; Iwamoto H; Kimura S; Nagai J; Kurosawa K; Yamashita S
    Brain Dev; 2010 Oct; 32(9):703-7. PubMed ID: 20022439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
    Laukka JJ; Kamholz J; Bessert D; Skoff RP
    Neurosci Lett; 2016 Aug; 627():222-32. PubMed ID: 27222925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteolipid protein gene mutation induces altered ventilatory response to hypoxia in the myelin-deficient rat.
    Miller MJ; Haxhiu MA; Georgiadis P; Gudz TI; Kangas CD; Macklin WB
    J Neurosci; 2003 Mar; 23(6):2265-73. PubMed ID: 12657685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.
    Sima AA; Pierson CR; Woltjer RL; Hobson GM; Golden JA; Kupsky WJ; Schauer GM; Bird TD; Skoff RP; Garbern JY
    Acta Neuropathol; 2009 Oct; 118(4):531-9. PubMed ID: 19562355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.